Preparing for Lab Inspections

🚨 If USFDA Walks In Tomorrow – Are You Ready? In pharmaceutical manufacturing, compliance is not a preparation for inspection. It is a daily habit. If the U.S. Food and Drug Administration walks into your facility tomorrow morning without notice… Can you confidently say: ✔ All logbooks are filled in real-time? ✔ No backdated entries? ✔ Audit trails are reviewed and justified? ✔ Deviations are scientifically investigated? ✔ CAPA is effective, not just documented? ✔ Cleaning and line clearance records are complete? ✔ Environmental monitoring trends are reviewed? ✔ Data integrity is maintained without shortcuts? Remember: Regulators don’t only check documents. They check culture. They observe: • Operator behavior • Gowning practices • Area discipline • Documentation habits • Management involvement Inspection readiness is not about fear. It is about building a system where compliance becomes automatic. In sterile manufacturing, one weak practice can lead to: ⚠ Warning letter ⚠ Import alert ⚠ Product recall ⚠ Loss of trust True GMP means you are always ready — even on a random Tuesday morning. Ask yourself today: Are we inspection-ready… or inspection-preparing? Because in pharma, we don’t manufacture products. We manufacture patient safety and trust. #USFDA #GMP #PharmaCompliance #InspectionReady #SterileManufacturing #AsepticProcessing #DataIntegrity #AuditReadiness #QualityCulture #PharmaceuticalIndustry #RegulatoryCompliance #WarningLetter #ImportAlert #CAPA #DeviationManagement #GoodManufacturingPractice #PharmaLife #Cleanroom #EnvironmentalMonitoring #LineClearance #AuditTrail #PatientSafety #ZeroTolerance #QualityFirst #PharmaProfessionals #ManufacturingExcellence #ComplianceMatters #PharmaCareer #DrugSafety #InspectionDay

𝐘𝐨𝐮 𝐝𝐨𝐧’𝐭 𝐫𝐞𝐚𝐥𝐥𝐲 𝐤𝐧𝐨𝐰 𝐢𝐟 𝐲𝐨𝐮’𝐫𝐞 𝐫𝐞𝐚𝐝𝐲 𝐟𝐨𝐫 𝐚𝐧 𝐢𝐧𝐬𝐩𝐞𝐜𝐭𝐢𝐨𝐧… 𝐮𝐧𝐭𝐢𝐥 𝐬𝐨𝐦𝐞𝐨𝐧𝐞 𝐝𝐞𝐥𝐢𝐛𝐞𝐫𝐚𝐭𝐞𝐥𝐲 𝐦𝐚𝐤𝐞𝐬 𝐲𝐨𝐮𝐫 𝐝𝐚𝐲 𝐝𝐢𝐟𝐟𝐢𝐜𝐮𝐥𝐭. Today, I wasn’t looking for missing documents. I wasn’t checking policies. I wasn’t reviewing procedures. Instead, I became 𝐭𝐡𝐞 𝐝𝐢𝐟𝐟𝐢𝐜𝐮𝐥𝐭 𝐢𝐧𝐬𝐩𝐞𝐜𝐭𝐨𝐫. An inspector who interrupts. An inspector who asks unexpected questions. An inspector who changes topics without warning. An inspector who asks for evidence immediately. Not because I wanted to make the team uncomfortable… …but because 𝐫𝐞𝐚𝐥 𝐢𝐧𝐬𝐩𝐞𝐜𝐭𝐢𝐨𝐧𝐬 𝐚𝐫𝐞 𝐧𝐨𝐭 𝐣𝐮𝐬𝐭 𝐚 𝐭𝐞𝐬𝐭 𝐨𝐟 𝐜𝐨𝐦𝐩𝐥𝐢𝐚𝐧𝐜𝐞—𝐭𝐡𝐞𝐲 𝐚𝐫𝐞 𝐚 𝐭𝐞𝐬𝐭 𝐨𝐟 𝐩𝐞𝐨𝐩𝐥𝐞. One realization stood out. Most laboratories spend months preparing documents. Far fewer prepare people. The first few minutes of an inspection often shape everything that follows. Confidence, communication, teamwork, ownership, and professionalism can build trust immediately—or create doubt before a single document is reviewed. This year, our challenge was even greater. For the first time, we are transitioning from a 𝐩𝐚𝐩𝐞𝐫-𝐛𝐚𝐬𝐞𝐝 𝐢𝐧𝐬𝐩𝐞𝐜𝐭𝐢𝐨𝐧 𝐭𝐨 𝐚 𝐟𝐮𝐥𝐥𝐲 𝐩𝐚𝐩𝐞𝐫𝐥𝐞𝐬𝐬 𝐢𝐧𝐬𝐩𝐞𝐜𝐭𝐢𝐨𝐧. That changes the dynamics completely. In the past, asking someone to “bring the folder” naturally created a few minutes to coordinate, verify, and prepare the next discussion. In a digital environment, that buffer disappears. Now the team must retrieve evidence instantly while maintaining a confident, professional conversation with the inspector. Technology, communication, and teamwork become one seamless process. That was the real purpose of today’s mock survey. We focused on three areas: ✅ 𝐇𝐮𝐦𝐚𝐧 𝐟𝐚𝐜𝐭𝐨𝐫𝐬 𝐚𝐧𝐝 𝐢𝐧𝐬𝐩𝐞𝐜𝐭𝐨𝐫 𝐦𝐚𝐧𝐚𝐠𝐞𝐦𝐞𝐧𝐭 How we communicate, respond under pressure, and maintain inspector confidence. ✅ 𝐏𝐚𝐩𝐞𝐫𝐥𝐞𝐬𝐬 𝐢𝐧𝐬𝐩𝐞𝐜𝐭𝐢𝐨𝐧 𝐫𝐞𝐚𝐝𝐢𝐧𝐞𝐬𝐬 Can we retrieve the right evidence quickly while keeping the inspection flowing naturally? ✅ 𝐈𝐓 𝐚𝐧𝐝 𝐓𝐞𝐜𝐡𝐧𝐢𝐜𝐚𝐥 𝐫𝐞𝐚𝐝𝐢𝐧𝐞𝐬𝐬 Are our systems, permissions, devices, and digital infrastructure truly inspection-ready? One lesson keeps repeating itself in healthcare, finance, and every high-performing organization: 𝐏𝐫𝐞𝐩𝐚𝐫𝐚𝐭𝐢𝐨𝐧 𝐢𝐬𝐧’𝐭 𝐚𝐛𝐨𝐮𝐭 𝐡𝐚𝐯𝐢𝐧𝐠 𝐭𝐡𝐞 𝐚𝐧𝐬𝐰𝐞𝐫𝐬. 𝐈𝐭’𝐬 𝐚𝐛𝐨𝐮𝐭 𝐩𝐫𝐨𝐯𝐢𝐧𝐠 𝐲𝐨𝐮 𝐜𝐚𝐧 𝐜𝐨𝐧𝐬𝐢𝐬𝐭𝐞𝐧𝐭𝐥𝐲 𝐟𝐢𝐧𝐝, 𝐞𝐱𝐩𝐥𝐚𝐢𝐧, 𝐚𝐧𝐝 𝐝𝐞𝐦𝐨𝐧𝐬𝐭𝐫𝐚𝐭𝐞 𝐭𝐡𝐞 𝐫𝐢𝐠𝐡𝐭 𝐚𝐧𝐬𝐰𝐞𝐫—𝐜𝐚𝐥𝐦𝐥𝐲, 𝐜𝐨𝐧𝐟𝐢𝐝𝐞𝐧𝐭𝐥𝐲, 𝐚𝐧𝐝 𝐚𝐬 𝐨𝐧𝐞 𝐭𝐞𝐚𝐦. Because in the end… Inspectors don’t only assess your documents. 𝐓𝐡𝐞𝐲 𝐚𝐬𝐬𝐞𝐬𝐬 𝐲𝐨𝐮𝐫 𝐜𝐮𝐥𝐭𝐮𝐫𝐞. #HealthcareQuality #LaboratoryMedicine #Pathology #Leadership #QualityManagement #DigitalTransformation #CBAHI #Accreditation #HealthcareLeadership #PatientSafety #Teamwork

Most labs treat a CAP inspection like a final exam. They cram for sixty days. Scrub the SOPs. Rehearse the answers. Then exhale when the inspector leaves — and let the discipline slide until the next window opens. Here's the problem: CAP inspections are unannounced. You get a three-month window, not a date. The old game of predicting your day and sprinting to meet it was designed out of existence. So the reframe that matters is this — readiness isn't an event. It's a state of being. Think of a professional kitchen. A good one doesn't clean differently the day the health inspector walks in. The standard is baked into every shift. It doesn't matter when someone shows up, because the answer is always the same: we're clean right now. That's the whole discipline. And it exposes an uncomfortable truth: If your lab needs a special effort to get ready for CAP, that effort is diagnostic. It's telling you exactly where your everyday operation is thin. The best-run labs don't pass inspections because they prepared. They pass because a genuinely well-run laboratory produces the same evidence an inspector is looking for — as a byproduct of just operating well. Competency files a stranger can follow. QC failures with documented corrective action. A self-inspection you actually walked, not just signed. A culture where the bench tech talks openly to the inspector instead of hiding the thing you'd most want found early. Compliance and operational excellence were never two projects. They're the same project. The inspection just confirms which one you've been running. How does your lab treat the gap between inspections — as downtime, or as the real work? #LaboratoryStewardship #CAP #ClinicalLaboratory #HealthcareLeadership #LabMedicine

I started my pharma/biotech career many years ago in a CAP/CLIA lab, eventually moving from operations into quality assurance management. One of the routine activities we would do when the College of American Pathologists (CAP) would release their updated checklists was to perform a gap analysis against any new requirements and revisit any others to ensure we reflected our current practices. Each discipline supervisor/manager was asked to go item by item and fill in how the laboratory complied with each requirement on their portion of the checklists. We would then review their checklists together to ensure consensus. I'm certain this was common practice at most CAP-accredited laboratories, but realizing the potential benefits was crucial so that it wasn't relegated to just another checkbox exercise. This served as our storyboard in a way as it helped each department to be able to tell the story of how each requirement was met at our facilities. This was tremendously helpful when it came to facing auditors who would visit. Knowing compliance requirements is one thing, while knowing specifically how your organization meets those requirements is another. Being able to succinctly and cohesively speak about your procedures and processes during audits is incredibly impactful. What are some audit readiness and training strategies that you've seen or used that were successful? I expect these will be varied as every organization is different culturally and dependent on the services you are providing as well. #qualityassurance #regulatorycompliance

“The inspector’s at the gate.” That’s how the call started. No warning. No prep day. Just a knock on the door at 8:03 a.m. But this time? We didn’t scramble. We welcomed them in, offered coffee, and got to work. Because inspection readiness wasn’t a project. It was a practice. ⸻ 🧬 In biopharma, inspection-readiness isn’t about the audit. It’s about operational integrity. When you’re always ready, inspections become confirmation—not crisis. ⸻ 🔎 7 Steps to Be Ready—Always 1️⃣ Make Quality a Daily Habit Inspections shouldn’t change how we behave. Embed quality into your routines so audit-day looks like every day. 2️⃣ Prepare Your People, Not Just Paper 60% of FDA 483s stem from personnel issues. Train SMEs to be clear, confident, and calm under pressure. 3️⃣ Build a Back Room That Works Create a command center: document runners, scribes, response leads. Drill until “smooth” becomes your standard. 4️⃣ Simplify Document Access Can your team retrieve a deviation in 60 seconds? If not, you’re not ready. 5️⃣ Lead with Data, Not Reactions Inspectors want facts. Bring metrics, CAPA outcomes, and trends—ready and translated into your quality language. 6️⃣ Audit Yourself—Ruthlessly Run mock inspections quarterly. Use real checklists from FDA 483s and EMA findings. 7️⃣ Stay Curious, Not Complacent Read inspection reports across the industry. What blindsided them could blindside you. ⸻ 📊 Stat to Remember 72% of FDA 483s in biologics cite repeat issues. Being almost ready isn’t enough. ⸻ 🚀 What’s your 365-day inspection-readiness strategy? Drop a best practice below, or ♻️tag someone who runs a world-class audit program. ⸻ You could also save this post to use at your next team huddle. #GMP #InspectionReadiness #Biopharma #QualityLeadership #FDA #Compliance #PharmaQuality #OperationalExcellence #CGT #QualityCulture

𝐈𝐧𝐬𝐩𝐞𝐜𝐭𝐢𝐨𝐧 𝐑𝐞𝐚𝐝𝐢𝐧𝐞𝐬𝐬: 𝐉𝐮𝐬𝐭 𝐁𝐞𝐟𝐨𝐫𝐞 𝐨𝐫 𝐀𝐥𝐥 𝐭𝐡𝐞 𝐓𝐢𝐦𝐞? “𝐈𝐧𝐬𝐩𝐞𝐜𝐭𝐢𝐨𝐧 𝐑𝐞𝐚𝐝𝐢𝐧𝐞𝐬𝐬 𝐈𝐬𝐧’𝐭 𝐚 𝐒𝐞𝐚𝐬𝐨𝐧, 𝐈𝐭’𝐬 𝐚 𝐒𝐭𝐚𝐭𝐞 𝐨𝐟 𝐌𝐢𝐧𝐝” Let’s be honest, how many teams scramble into “inspection readiness mode” only when they get notified of an audit or a regulatory visit? 📅 𝐓𝐡𝐞 𝐩𝐫𝐨𝐛𝐥𝐞𝐦? Inspection readiness is treated like an event. A checklist. A season that comes and goes. But in a world where quality is non-negotiable and regulations are evolving, this mindset doesn’t work. 🔁 𝐓𝐫𝐮𝐞 𝐑𝐞𝐚𝐝𝐢𝐧𝐞𝐬𝐬 = 𝐂𝐨𝐧𝐭𝐢𝐧𝐮𝐨𝐮𝐬 𝐑𝐞𝐚𝐝𝐢𝐧𝐞𝐬𝐬. It means: 1️⃣ Your documentation is always accurate and audit ready. 2️⃣ Your teams are always trained, not just refreshed, before an inspection. 3️⃣ Your CAPAs are meaningful, not rushed responses to auditor questions. 4️⃣ Your QMS is living, not a forgotten binder. 🎯 𝐖𝐡𝐚𝐭 𝐈𝐧𝐬𝐩𝐞𝐜𝐭𝐢𝐨𝐧 𝐑𝐞𝐚𝐝𝐢𝐧𝐞𝐬𝐬 𝐒𝐡𝐨𝐮𝐥𝐝 𝐋𝐨𝐨𝐤 𝐋𝐢𝐤𝐞: 💠 SOPs that are known, understood, and applied 💠 Ongoing training, not just crash courses 💠 Regular internal audits and mock inspections 💠 Clear roles and expectations around compliance 💠 A culture of proactive quality, not reactive fixes 💡 𝐊𝐞𝐲 𝐓𝐚𝐤𝐞𝐚𝐰𝐚𝐲: Inspection readiness isn’t a season. It’s a state of mind. Teams that embed quality into their everyday processes don’t fear audits or inspections, they’re ready for them daily. #InspectionReadiness #ClinicalTrials #QA #ClinicalResearch #Audit #QMS #ICHGCP #SOPs #CAPA #GxP #Regulations #Inspections

Quality Oversight That is the whole case for what ICH E6(R3) means by inspection readiness. R3 does not treat inspection as an event you prepare for. It treats the evidence of control as something that should exist continuously, throughout the trial. Oversight that you can show, while the study runs, not reconstruct afterwards. For sponsors and CROs, that is an operational standard, not a filing one. You need to demonstrate that oversight happened. That qualifications were current. That deviations were captured and escalated when they occurred. That the data trail holds. If you can only assemble that picture under pressure, after the request lands, you were not ready. You were lucky, until you were not. The two products in this space cover the two halves of that continuous evidence. VendorVigilance, on the vendor oversight side: 📌 Qualification, risk, and oversight evidence assembled continuously, not reconstructed before a visit 📌 Every delegation, restriction, and CAPA recorded with its rationale and date 📌 A live trail of who oversaw which vendor, and when, ready when an inspector asks TrialTrack, on the study management side: 📌 Study state, tasks, milestones, sites, and participants connected in one view 📌 An ALCOA++ compliant audit trail so the study evidence is available, not rebuilt 📌 Monitoring and deviation signals visible while the study runs, not fifteen months later Purpose-built systems for vendor oversight and for study-level trial management are how inspection readiness becomes a continuous state rather than a pre-inspection scramble.

🔥 🔍 𝗕𝘂𝗶𝗹𝗱𝗶𝗻𝗴 𝗜𝗻𝘀𝗽𝗲𝗰𝘁𝗶𝗼𝗻-𝗥𝗲𝗮𝗱𝘆 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗧𝗿𝗶𝗮𝗹 𝗦𝗶𝘁𝗲𝘀 𝗶𝗻 𝘁𝗵𝗲 𝗨𝗔𝗘 & 𝗦𝗮𝘂𝗱𝗶 𝗔𝗿𝗮𝗯𝗶𝗮 Across the GCC, we’re witnessing remarkable progress, from dedicated research units to increasing sponsor confidence. Yet one area still offers huge potential for growth: 𝘁𝗿𝘂𝗲 𝗶𝗻𝘀𝗽𝗲𝗰𝘁𝗶𝗼𝗻 𝗿𝗲𝗮𝗱𝗶𝗻𝗲𝘀𝘀. Many sites are operationally prepared, but inspection readiness is more than having documents well-organised. It’s about predictable quality under pressure: the ability to demonstrate that every process, record, and delegation aligns with Good Clinical Practice in real time, every day. That level of consistency is what inspires long-term trust from sponsors and regulators and 𝘄𝗵𝗮𝘁 𝘂𝗹𝘁𝗶𝗺𝗮𝘁𝗲𝗹𝘆 𝗮𝘁𝘁𝗿𝗮𝗰𝘁𝘀 𝗺𝗼𝗿𝗲 𝗰𝗼𝗺𝗺𝗲𝗿𝗰𝗶𝗮𝗹𝗹𝘆 𝘀𝗽𝗼𝗻𝘀𝗼𝗿𝗲𝗱 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝘁𝗿𝗶𝗮𝗹𝘀 𝘁𝗼 𝗼𝘂𝗿 𝗿𝗲𝗴𝗶𝗼𝗻. 𝗛𝗲𝗿𝗲’𝘀 𝘄𝗵𝗮𝘁 𝗱𝗶𝘀𝘁𝗶𝗻𝗴𝘂𝗶𝘀𝗵𝗲𝘀 𝗶𝗻𝘀𝗽𝗲𝗰𝘁𝗶𝗼𝗻-𝗿𝗲𝗮𝗱𝘆 𝘀𝗶𝘁𝗲𝘀 𝘁𝗵𝗮𝘁 𝘀𝘁𝗮𝗻𝗱 𝗼𝘂𝘁 𝗴𝗹𝗼𝗯𝗮𝗹𝗹𝘆: 🔸 𝗗𝗼𝗰𝘂𝗺𝗲𝗻𝘁𝗲𝗱 𝘁𝗿𝗮𝗰𝗲𝗮𝗯𝗶𝗹𝗶𝘁𝘆: showing not just what was done, but why and how each decision was made. 🔸 𝗢𝘃𝗲𝗿𝘀𝗶𝗴𝗵𝘁 𝗮𝘄𝗮𝗿𝗲𝗻𝗲𝘀𝘀: investigators who see quality as shared accountability, not delegated responsibility. 🔸 𝗗𝗮𝘁𝗮 𝗰𝘂𝗹𝘁𝘂𝗿𝗲: accuracy and transparency as part of daily workflow, not just audit exercises. 🔸 𝗖𝗿𝗼𝘀𝘀-𝗳𝘂𝗻𝗰𝘁𝗶𝗼𝗻𝗮𝗹 𝗿𝗲𝗮𝗱𝗶𝗻𝗲𝘀𝘀: coordinators, pharmacists, and data staff aligned on the same evidence expectations. Let’s move from reactive compliance to proactive excellence with a shift that begins with daily practice, not inspection-day preparation. 𝗛𝗲𝗿𝗲 𝗮𝗿𝗲 𝗳𝗶𝘃𝗲 𝘄𝗮𝘆𝘀 𝗶𝗻𝘃𝗲𝘀𝘁𝗶𝗴𝗮𝘁𝗼𝗿 𝘀𝗶𝘁𝗲𝘀 𝗰𝗮𝗻 𝗹𝗲𝗮𝗱 𝘁𝗵𝗶𝘀 𝗰𝗵𝗮𝗻𝗴𝗲: 1️⃣ Build “evidence-as-you-go” habits Make contemporaneous documentation part of the routine. If it’s not documented, it didn’t happen. 2️⃣ Run internal mock inspections Practise storytelling around your data. In fact, inspections become easier when teams know how to communicate their quality journey. 3️⃣ Empower the entire team Everyone, from CRCs to IT support, should understand why compliance matters. Ownership builds confidence. 4️⃣ Create visibility dashboards Use digital tools to monitor deviations, open queries, and missing data. Transparency drives readiness. 5️⃣ Make training practical Replace theory with real-world examples from your own studies. Context turns learning into behaviour. The UAE and Saudi Arabia are already investing heavily in genomic medicine, digital health, and AI-enabled research. ✨ Now it’s time to complement that innovation with operational excellence: ensuring that when global sponsors look at the GCC, they see a region that is not only capable but consistently inspection-ready and trusted. #ClinicalTrials #InspectionReadiness #GCP #ResearchQuality #UAE #SaudiArabia #InvestigatorSites #LifeSciences #PharmaInnovation

Preparing for an FDA inspection requires a strategic approach, and having expert guidance can ensure everything runs smoothly. Key Areas to Focus On for FDA Inspection Readiness: GMP Documentation Review - Ensure SOPs, batch records, and training logs are complete, current, and easily accessible. - Verify that change control, CAPAs, deviations, and complaints are properly documented and closed out. Mock FDA Audits & Readiness Training - Conduct a mock inspection to identify gaps before the FDA does. - Train staff on inspection behavior, common FDA questions, and how to present information effectively. Data Integrity & Quality Systems Assessment - Ensure electronic systems comply with 21 CFR Part 11 (audit trails, access controls, data accuracy). - Confirm that laboratory and manufacturing records are accurate, attributable, and traceable. Facility Walkthrough & Housekeeping - Ensure the facility is clean, well-maintained, and compliant with cGMP requirements. - Review storage conditions, labeling, and equipment calibration logs. Regulatory Risk Assessment & Compliance Gap Closure - Identify potential risks that could lead to 483 observations or warning letters. - Close out pending CAPAs and deviations before the inspection. Inspection-Day Preparedness - Establish roles and responsibilities (who speaks, who retrieves documents, who takes notes). - Prepare a war room for document retrieval and regulatory references. - Rehearse responses to tough FDA questions to ensure confidence and accuracy. Would you like a tailored FDA inspection readiness plan based on your company’s unique risk profile and regulatory history?

𝗛𝗼𝘄 𝘁𝗼 𝗥𝗲𝘀𝗽𝗼𝗻𝗱 𝗪𝗵𝗲𝗻 𝗙𝗗𝗔 𝗜𝗻𝘀𝗽𝗲𝗰𝘁𝗼𝗿𝘀 𝗦𝘂𝗱𝗱𝗲𝗻𝗹𝘆 𝗔𝗿𝗿𝗶𝘃𝗲 𝗮𝘁 𝗬𝗼𝘂𝗿 𝗙𝗮𝗰𝗶𝗹𝗶𝘁𝘆. When FDA investigators arrive unannounced at your facility, your immediate response in the first few minutes will set the tone for the entire inspection. Having a trained personnel ready to respond can transform what might seem like a crisis into a successful demonstration of your commitment to compliance 1. Immediate Response ✓ Request and verify FDA credentials inspectors must present their official FDA-issued badge ✓ Request the FDA Form 482 Notice of Inspection ✓ Immediately notify the senior QA personal ✓ Escort inspectors to a designated inspection room - not directly into production areas ✓ Record all information from the inspector's identification. ✓ Note the stated purpose and scope of the inspection and document whether the inspection is routine, for-cause, or follow-up 2. Activate Your Inspection Team: ✓ FDA Escort Must accompany the investigator at all times throughout the facility ✓ Document retrieval, review, and preparation ✓ Ensure ready for SMEs personnel knowledgeable about specific processes and systems ✓ Have basic knowledge to answer simple questions rapidly ✓ Coordinate all FDA requests and ensure questions are answered honestly and completely ✓ Guide the investigator to appropriate subject matter experts ✓ Facilitate communication between the investigator and site personnel 3. QA Responsibilities ✓Site Master File and organizational chart ✓ SOP Master Index and key procedures ✓ Product list ✓ List of deviations, change controls, OOS investigations, and CAPAs since last inspection ✓ Responses to prior FDA 483 observations and related CAPAs ✓ Provide only requested documents - nothing extra ✓ Inform all relevant staff that inspection is in progress ✓ Remind staff to keep documents off desks and counters ✓ Alert personnel about inspector movements throughout the facility 4. Facility Readiness ✓ Label everything - equipment, calibration stickers must be current ✓ Remove or properly label out-of-service equipment ✓ Address facility maintenance - repair cracks, paint damage ✓ Clear unauthorized procedures from desks and walls ✓ Review status labeling in all storage areas 5. How to Respond to Inspector Questions: ✓ Listen carefully and answer only the question asked be concise, clear, and confident ✓ Use supporting documentation when available ✓ Defer to subject matter experts when you don't know the answer ✓ DO NOT volunteer extra information or speculate 6. Addressing Observations ✓Clarify the observation to ensure accurate understanding ✓ Present immediate corrective actions if already implemented ✓ Provide objective evidence of any corrections made ✓ Prepare for FDA Form 483 if observations are issued ✓ Plan preliminary response within 15 business days ✓ Document all inspection-related communications